2021
DOI: 10.26434/chemrxiv.14233418
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Machine Learning Designs Non-Hemolytic Antimicrobial Peptides

Abstract: <p>Machine learning (ML) consists in the recognition of patterns from training data and offers the opportunity to exploit large structure-activity database sets for drug design. In the area of peptide drugs, ML is mostly being tested to design antimicrobial peptides (AMPs), a class of biomolecules potentially useful to fight multidrug resistant bacteria. ML models have successfully identified membrane disruptive amphiphilic AMPs, however without addressing the associated toxicity to human red blood cells… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(26 citation statements)
references
References 0 publications
0
26
0
Order By: Relevance
“…This system has taken into account a powerful tool to learn from data (Lee et al., 2018; Li et al., 2018). It allows users to generate new molecules and predict their characteristics and activity using the experimental structure of known drugs (Capecchi et al., 2021). Now, the machine learning model has been applied to the prediction of bioactive peptides.…”
Section: Introductionmentioning
confidence: 99%
“…This system has taken into account a powerful tool to learn from data (Lee et al., 2018; Li et al., 2018). It allows users to generate new molecules and predict their characteristics and activity using the experimental structure of known drugs (Capecchi et al., 2021). Now, the machine learning model has been applied to the prediction of bioactive peptides.…”
Section: Introductionmentioning
confidence: 99%
“…Our predictive model for the solubility task has the lowest accuracy of 69.0% amongst all, and this is mostly attributed to the difficulty associated with solubility prediction in bioinformatics. The one-hot representation of peptides followed by an RNN results the best hemolysis model in terms of AUROC in [64]. The choice of one-hots requires training features specific to each position though, so we do not expect the model to generalize.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, XGBC-Hem performs feature selection to improve the performance of the model. Lastly, the dataset from [12], referred to in this work as RNN-Hem, is selected as the third benchmark, since this work uses a sequence-based deep learning model to predict the hemolytic activity of peptides. All three datasets offer training sets and independent test sets consisting of therapeutic peptides and antimicrobial peptides, which will be used to train and evaluate the classification pipeline.…”
Section: Data Aggregationmentioning
confidence: 99%